Trials / Completed
CompletedNCT00372307
Efficacy and Safety of Pimecrolimus for the Treatment of Vitiligo Vulgaris
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 26 (planned)
- Sponsor
- University Hospital, Ghent · Academic / Other
- Sex
- All
- Age
- 6 Years
- Healthy volunteers
- Not accepted
Summary
Patients with vitiligo vulgaris are treated with Pimecrolimus twice a day during 6 months. After a baseline visit, patient returns for a control visit after 3 and 6 months of treatment. One reference lesion is clinically evaluated with pictures.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Application of pimecrolimus |
Timeline
- Start date
- 2004-05-01
- Completion
- 2004-11-01
- First posted
- 2006-09-06
- Last updated
- 2007-12-28
Locations
1 site across 1 country: Belgium
Source: ClinicalTrials.gov record NCT00372307. Inclusion in this directory is not an endorsement.